Gluconaut is here!
No tubes. No limits. Pure power.
Omnipod and Marvel have come together again to create another custom Marvel comic that normalizes diabetes technology and empowers people with diabetes to be confident being themselves. Penned by a writer with diabetes, this isn't just a thrilling read-it's a celebration of representation.
Meet Podrick
Podrick is a high school student fascinated by all things space. But managing his type 1 diabetes hasn't been easy—he feels like he's struggling to fit in, his confidence is low and his energy level is even lower. When his good friend Arman begins acting strangely, he doesn't even notice-until he puts on an Omnipod 5. Confident, focused and with his glucose levels in range, Podrick transforms into Gluconaut just in time. Read all about it in Gluconaut: Strength of Stars.
Looking for our first edition?
Omnya is an ordinary high school student who loves science and technology and struggles to manage her type 1 diabetes. And, when she least expects it, the villainous D'Spayre creeps into every aspect of her life. With an Omnipod 5 on her arm, Omnya learns that when her glucose levels are in range, she can take on anything or anyone. Read about Omnya's epic transformation into Dyasonic in Dyasonic: Sound of Strength.
Pod power
Discover your power with Omnipod 5. It's tubeless, waterproof* and delivers insulin for up to 3 days (72 hours).
*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.
Risk Statement
The Omnipod 5 Automated Insulin Delivery System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older and type 2 diabetes mellitus in persons 18 years of age and older. The Omnipod® 5 System is intended for single patient, home use and requires a prescription. The Omnipod® 5 System is compatible with the following U-100 insulins: NovoLog®, Humalog®, Kirsty®, and Admelog®.
The Omnipod® 5 ACE Pump (Pod) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod® 5 ACE Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values.
The Omnipod® 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value.
Warning: SmartAdjust™ technology should NOT be used by anyone under the age of 2 years old.
SmartAdjust™ technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod® 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod® 5 System according to instructions, are taking hydroxyurea and using a Dexcom Sensor as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod® 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller and smartphone should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components.
Visit www.omnipod.com/safety for additional important safety information.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.
INS-OHS-05-2026-00391 V1.0